"Cancer Genomics" 6 posts Sort by created date Sort by defined ordering View as a grid View as a list
The goal of these multi-week activities is to use Cancer Biology as a theme to introduce concepts in the cell cycle, cell biology, genetics and signal transduction.
These activities are appropriate for high school and Introductory Biology classes.
Learning Objectives:
0 likes 0 comments 2 reposts
Alice Tarun onto Cancer Genomics @ 9:37 am on 19 Jan 2017
Uses:
0 likes 0 comments 1 reposts
Melissa Haswell onto Cancer Genomics @ 12:41 pm on 31 Dec 2016
In the 2013 Holiday Lectures on Science, leading medical researchers explain how advances in genomics are revolutionizing their work, leading to a better understanding of disease and to improved treatments.
Gabriela Hamerlinck onto Cancer Genomics @ 10:21 am on 26 Feb 2016
Explore the phases, checkpoints, and protein regulators of the cell cycle in this highly interactive Click and Learn and find out how mutated versions of these proteins can lead to the development of cancer.
These two hands-on activities are based on a Howard Hughes Medical Institute 2013 Holiday Lectures on Science video featuring researcher Dr. Charles L. Sawyers.
Abstract: Over the past decade, comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer. For most cancer types, this landscape consists of a small number of “mountains” (genes altered in a high percentage of tumors) and a much larger number of “hills” (genes altered infrequently). To date, these studies have revealed ~140 genes that, when altered by intragenic mutations, can promote or “drive” tumorigenesis. A typical tumor contains two to eight of these “driver gene” mutations; the remaining mutations are passengers that confer no selective growth advantage. Driver genes can be classified into 12 signaling pathways that regulate three core cellular processes: cell fate, cell survival, and genome maintenance. A better understanding of these pathways is one of the most pressing needs in basic cancer research. Even now, however, our knowledge of cancer genomes is sufficient to guide the development of more effective approaches for reducing cancer morbidity and mortality.